Sphingomyelin Synthase 1 (SMS1) is a pivotal enzyme in sphingolipid metabolism, orchestrating the synthesis of sphingomyelin from ceramide and phosphatidylcholine. This enzyme resides primarily within the Golgi apparatus, a cellular organelle crucial for processing and shipping lipids and proteins. SMS1 plays a central role in maintaining the dynamic balance of sphingolipids, which are not only structural components of cellular membranes but also participate in signaling pathways that govern a plethora of cellular processes. The activity of SMS1 is essential for the proper organization of lipid rafts, membrane domains rich in cholesterol and sphingolipids, which are vital for signal transduction and membrane fluidity. The regulation of SMS1 expression is a finely tuned process, influenced by a complex network of signaling molecules and metabolic conditions within the cell. Understanding the regulation of SMS1 is important for comprehending how cells modulate their membrane composition and respond to changes in their environment.
Several chemical compounds have been identified that may influence the expression of SMS1, though their exact mechanisms of action can be highly context-dependent and multifaceted. Compounds such as retinoic acid and Vitamin D3, for example, are known to interact with nuclear receptors, which in turn can initiate transcriptional programs that include the upregulation of certain enzymes involved in lipid metabolism. Similarly, oxysterols like 25-Hydroxycholesterol may serve as feedback regulators, potentially stimulating the expression of SMS1 to adjust cellular lipid profiles. On another front, secondary messengers such as cyclic AMP (cAMP) are implicated in a myriad of signaling cascades and could lead to enhanced SMS1 expression through the activation of protein kinases that target specific transcription factors. Moreover, bioactive molecules like sphingosine-1-phosphate may exert their influence on SMS1 expression by binding to their cognate receptors, thereby activating downstream signaling pathways that culminate in the modulation of gene expression. It is through the concerted action of such molecules that cells can fine-tune the levels of SMS1, thereby maintaining lipid homeostasis and ensuring proper cellular function.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid can bind to retinoid receptors, which may initiate the transcription of genes including those related to sphingolipid metabolism, thereby potentially stimulating an increase in SMS1 enzyme levels. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
The active form of Cholecalciferol interacts with its specific nuclear receptor, which could trigger a cascade of gene expression changes, including the upregulation of SMS1 to adjust cellular functions such as lipid synthesis. | ||||||
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $52.00 $89.00 $166.00 $465.00 | 8 | |
This oxysterol can engage in feedback control mechanisms within lipid metabolic pathways, potentially prompting an upsurge in SMS1 expression to maintain sphingolipid equilibrium within membranes. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $117.00 $469.00 | 18 | |
Inhibiting ceramide synthase, Fumonisin B1 may create a compensatory response in sphingolipid biosynthesis, leading to an upregulation of SMS1 as the cell attempts to reestablish lipid homeostasis. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
As a bioactive lipid mediator, D-erythro-Sphingosine-1-phosphate can engage specific receptors that activate intracellular signaling cascades, potentially leading to the upregulation of SMS1 to balance intracellular sphingolipid levels. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $114.00 $175.00 $260.00 $362.00 $617.00 $1127.00 | ||
Adenosine 3',5'-cyclic monophosphate, a secondary messenger, can initiate protein kinase A (PKA) activation, which may then phosphorylate transcription factors, leading to an enhanced expression of SMS1 as part of the broader response to hormonal or environmental stimuli. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin is known to stimulate adenylate cyclase, resulting in an increase in cAMP levels and subsequently activating PKA, which could lead to an upregulation of SMS1 by enhancing the transcription of genes involved in sphingolipid metabolism. |